EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants

Letícia Tiburcio Ferreira, Gustavo Capatti Cassiano, Luis Carlos Salazar Alvarez, John Okombo, Juliana Calit, Diana Fontinha, Eva Gil-Iturbe, Rachael Coyle, Carolina Horta Andrade, Per Sunnerhagen, Daniel Youssef Bargieri, Miguel Prudêncio und 5 weitere

PLOS Pathogens · 29.10.2024 · 20 (10) · e1012627

DOI: 10.1371/journal.ppat.1012627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 29.10.2024. Verfasst von Letícia Tiburcio Ferreira und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, Department of Genetics, Evolution, Microbiology and Immunology, University of Campi…. Hauptthemen laut MEDLINE: Antimalarials, Plasmodium falciparum, Aminoquinolines, Protozoan Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artemisinin-based combination therapy (ACT) is the mainstay of effective treatment of Plasmodium falciparum malaria. However, the long-term utility of ACTs is imperiled by widespread partial artemisinin resistance in Southeast Asia and its recent emergence in parts of East Africa. This underscores the need to identify chemotypes with new modes of action (MoAs) to circumvent resistance to ACTs. In this study, we characterized the asexual blood stage antiplasmodial activity and resistance mechanisms of LDT-623, a 4-aminoquinoline (4-AQ). We also detected LDT-623 activity against multiple stages (liver schizonts, stage IV-V gametocytes, and ookinetes) of Plasmodium ’s life cycle, a feature unlike other 4-AQs such as chloroquine (CQ) and piperaquine (PPQ). Using heme fractionation profiling and drug uptake studies in PfCRT-containing proteoliposomes, we observed inhibition of hemozoin formation and PfCRT-mediated transport, which constitute characteristic features of 4-AQs’ MoA. We also found minimal cross-resistance to LDT-623 in a panel of mutant pfcrt or pfmdr1 lines, but not the PfCRT F145I mutant that is highly resistant to PPQ resistance yet is very unfit. No P. falciparum parasites were recovered in an in vitro resistance selection study, suggesting a high barrier for resistance to emerge. Finally, a competitive growth assay comprising >50 barcoded parasite lines with mutated resistance mediators or major drug targets found no evidence of cross-resistance. Our findings support further exploration of this promising 4-AQ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsPlasmodium falciparumAminoquinolinesProtozoan ProteinsMalaria, FalciparumMembrane Transport ProteinsATP-Binding Cassette, Sub-Family C ProteinsDrug ResistanceHumansMutation

Substanzen

AntimalarialsAminoquinolinesProtozoan ProteinsMembrane Transport ProteinsATP-Binding Cassette, Sub-Family C ProteinsPfCRT protein, Plasmodium falciparum4-aminoquinolineMdr1 protein, Plasmodium falciparum

Autor:innen und Institutionen

  • Laboratory of Tropical Diseases-Prof. Dr. Luiz Jacintho da Silva, Department of Genetics, Evolution, Microbiology and Immunology, University of Campinas-UNICAMP, Campinas, São Paulo, Brazil.
  • Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Center for Malaria Therapeutics and Antimicrobial Resistance, Columbia University Irving Medical Center, New York, New York, United States of America.
  • Global Health and Tropical Medicine, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, Lisboa, Portugal.
  • Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, São Paulo, Brazil.
  • Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal.

ORCID-Profile: Fabio Trindade Maranhão Costa

Förderung

  • NIAID NIH HHS
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • National Institutes of Health
  • National Institutes od Health
  • Fundação de Amparo à Pesquisa do Estado de Goiás
  • Instituto Serrapilheira
  • 'la Caixa' Foundation

Zitieren

APA

Ferreira, L. T., Cassiano, G. C., Alvarez, L. C. S., Okombo, J., Calit, J., Fontinha, D., Gil-Iturbe, E., Coyle, R., Andrade, C. H., Sunnerhagen, P., Bargieri, D. Y., Prudêncio, M., Quick, M., Cravo, P. V., Lee, M. C. S., Fidock, D. A., & Costa, F. T. M. (2024). A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants. PLOS Pathogens, 20(10), e1012627. https://doi.org/10.1371/journal.ppat.1012627

Vancouver

Ferreira LT, Cassiano GC, Alvarez LCS, Okombo J, Calit J, Fontinha D, et al. A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants. PLOS Pathogens. 2024;20(10):e1012627. doi:10.1371/journal.ppat.1012627

BibTeX
@article{Ferreira2024,
  author = {Ferreira, Letícia Tiburcio and Cassiano, Gustavo Capatti and Alvarez, Luis Carlos Salazar and Okombo, John and Calit, Juliana and Fontinha, Diana and Gil-Iturbe, Eva and Coyle, Rachael and Andrade, Carolina Horta and Sunnerhagen, Per and Bargieri, Daniel Youssef and Prudêncio, Miguel and Quick, Matthias and Cravo, Pedro V and Lee, Marcus C S and Fidock, David A and Costa, Fabio Trindade Maranhão},
  title = {A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants},
  journal = {PLOS Pathogens},
  year = {2024},
  volume = {20},
  number = {10},
  pages = {e1012627},
  doi = {10.1371/journal.ppat.1012627}
}
Kostenlos starten →